The use of a combination of cytostatics with substances influencing neuro-humoral regulation (K6) in the treatment of lung cancer.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001984:Bronchial Neoplasms / Q000188:drug therapy* / Q000601:surgery; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy; D004357:Drug Synergism; D006801:Humans; D006910:Hydroxypropiophenone / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000601:surgery; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D018377:Neurotransmitter Agents / Q000378:metabolism; D012110:Reserpine / Q000627:therapeutic use; D013997:Time Factors; D014520:Urethane / Q000627:therapeutic use
D000970:Antineoplastic Agents; D018377:Neurotransmitter Agents; D006910:Hydroxypropiophenone; D014520:Urethane; D012110:Reserpine; D015122:Mercaptopurine